Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.410
-0.050 (-3.42%)
Feb 21, 2025, 4:00 PM EST - Market closed
Erasca Market Cap
Erasca has a market cap or net worth of $398.65 million as of February 21, 2025. Its market cap has increased by 52.16% in one year.
Market Cap
398.65M
Enterprise Value
-11.72M
1-Year Change
52.16%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $398.65M, a decrease of -78.55%. That is a compound annual growth rate of -34.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 398.65M | -43.82% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |